Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 3541 AL 3555

Familial coaggregation of Alzheimer's disease and Parkinson's disease: systematic review and meta-analysis

Feldman AL, Johansson AL, Lambert PC, Sieurin J, Yang F, Pedersen NL, Wirdefeldt K.

Neuroepidemiology. 2014;42(2):69-80. doi: 10.1159/000355452. Epub 2013 Nov 30.

An emerging role of PARK2 in cancer

Xu L, Lin DC, Yin D, Koeffler HP.

J Mol Med (Berl). 2014 Jan;92(1):31-42. doi: 10.1007/s00109-013-1107-0. Epub 2013 Dec 3.

Comparison of pedometer and accelerometer derived steps in older individuals with Parkinson's disease or osteoporosis under free-living conditions

Wallén MB, Dohrn IM, Ståhle A, Franzén E, Hagströmer M.

J Aging Phys Act. 2014 Oct;22(4):550-6. doi: 10.1123/japa.2013-0052. Epub 2013 Dec 4.

Transient parkinsonism following mycoplasma pneumoniae infection with normal brain magnetic resonance imaging (MRI)

Tay CG, Fong CY, Ong LC.

J Child Neurol. 2014 Dec;29(12):NP193-5. doi: 10.1177/0883073813510741. Epub 2013 Dec 5.

Dopamine receptor agonists for Parkinson's disease

Blandini F, Armentero MT.

Expert Opin Investig Drugs. 2014 Mar;23(3):387-410. doi: 10.1517/13543784.2014.869209. Epub 2013 Dec 9.

Impulsive and compulsive behaviors in Parkinson's disease

Averbeck BB, O'Sullivan SS, Djamshidian A.

Annu Rev Clin Psychol. 2014;10:553-80. doi: 10.1146/annurev-clinpsy-032813-153705. Epub 2013 Dec 2.

Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials

Chondrogiorgi M, Tatsioni A, Reichmann H, Konitsiotis S.

Eur J Neurol. 2014 Mar;21(3):433-40. doi: 10.1111/ene.12318. Epub 2013 Dec 7.

Parkinson disease in long term care facilities: a review of the literature

Weerkamp NJ, Tissingh G, Poels PJ, Zuidema SU, Munneke M, Koopmans RT, Bloem BR.

J Am Med Dir Assoc. 2014 Feb;15(2):90-4. doi: 10.1016/j.jamda.2013.10.007. Epub 2013 Dec 4.

Parkinson's disease: less epileptic seizures, more status epilepticus

Feddersen B, Rémi J, Einhellig M, Stoyke C, Krauss P, Noachtar S.

Epilepsy Res. 2014 Feb;108(2):349-54. doi: 10.1016/j.eplepsyres.2013.11.013. Epub 2013 Nov 21.

Clinical and neuroimaging features of patient with early-onset Parkinson's disease with dementia carrying SNCA p.G51D mutation

Tokutake T, Ishikawa A, Yoshimura N, Miyashita A, Kuwano R, Nishizawa M, Ikeuchi T.

Parkinsonism Relat Disord. 2014 Feb;20(2):262-4. doi: 10.1016/j.parkreldis.2013.11.008. Epub 2013 Nov 20.

Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration

Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE.

Am J Ophthalmol. 2014 Feb;157(2):470-478.e2. doi: 10.1016/j.ajo.2013.09.028. Epub 2013 Oct 2.

Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports

Gaboriau L, Victorri-Vigneau C, Gérardin M, Allain-Veyrac G, Jolliet-Evin P, Grall-Bronnec M.

Addict Behav. 2014 Mar;39(3):562-5. doi: 10.1016/j.addbeh.2013.11.005. Epub 2013 Nov 10.

Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial

Constantinescu R, Elm J, Auinger P, Sharma S, Augustine EF, Khadim L, Kieburtz K; NET-PD Investigators.

Mov Disord. 2014 Feb;29(2):263-5. doi: 10.1002/mds.25734. Epub 2013 Dec 3.

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

Borgohain R, Szasz J, Stanzione P, Meshram C, Bhatt M, Chirilineau D, Stocchi F, Lucini V, Giuliani R, Forrest E, Rice P, Anand R; Study 016 Investigators.

Mov Disord. 2014 Feb;29(2):229-37. doi: 10.1002/mds.25751. Epub 2013 Dec 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias